Biblio
ULK1 inhibition promotes oxidative stress-induced differentiation and sensitizes leukemic stem cells to targeted therapy. Sci Transl Med. 2021;13(613):eabd5016.
Targeting BCR-ABL1-positive leukaemias: a review article. Camb Prism Precis Med. 2023;1:e21.
. Novel drug therapies in myeloid leukemia: a patent review. Pharm Pat Anal. 2015;4(3):187-205.
. In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial. Lancet Haematol. 2022;9(4):e276-e288.
Inhibition of mitochondrial folate metabolism drives differentiation through mTORC1 mediated purine sensing. Nat Commun. 2024;15(1):1931.